Escherichia Coli and Ulcerative Colitis

Seneca H , Henderson E. Normal intestinal bacteria in ulcerative colitis. Gastroenterology 1950; 15: 34–9.

Cooke EM . Properties of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J Path Bacteriol 1968; 95: 101–13.

Gorbach SL , Nahas L , Plaut AG , Weinstein L , Patterson JF , Levitan R. Studies of intestinal microflora V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology 1968; 54: 575–87.

Keighley MRB , Arabi Y , Dimock F , Burdon DW , Allan RN , Alexander-Williams J. Influence of inflammatory bowel disease on intestinal microflora. Gut 1978; 23: 410–14.

Hartley MG , Hudson M.J.E. T. S. , Gent AE , Hellier MD , Grace RH . Adnesive and hydrophobic properties of Escherichia coli isolated from a variety of sources. J Med Microbiol 1975; 8: 107–11.

Cooke EM . Escherichia coli and ulcerative colitis. MD thesis, University of London, 1966.

Cooke EM , Ewins S , Hywell-Jones J , Lennard-Jones JE . Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut 1974; 15: 143–6.

Dickinson RJ , Varian SA , Axon ATR , Cooke EM . Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut 1980; 21: 787–92.

Pinder IF , Dickinson RJ , Cooke EM , Axon ATR . High incidence of potentially pathogenic. E. coli in first attack of ideopathic colitis. Gut 1983; 24: A997.

Burke DA , Axon ATR . Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol 1987; 40: 782–6.

Burke DA , Axon ATR . HeLa and buccal epithelial cell adhesion assays for detecting intestinal Escherichia coli with adhesive properties in ulcerative colitis. J Clin Pathol 1987; 40: 1402–4.

Giaffer MH , Holdsworth CD , Buerden BI . Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut 1992; 33: 646–50.

Burke DA , Axon ATR . Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ 1988; 297: 102.

Burke DA , Clayden SA , Axon ATR . Sulfasalazine does not select for Escherichia coli with adhesive properties in ulcerative colitis. Lancet 1988; ii: 966.

Ljungh A , Eriksson M , Eriksson O , Henter JI , Wadstrom T. Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis. Scand J of Inf Dis 1988; 20: 443–6.

Burke DA . Escherichia coli and ulcerative colitis. MD thesis, University of Newcastle upon Tyne, 1990.

Dickinson RJ . Enteric infection and ulcerative colitis. MD thesis, University of London, 1982.

Dickinson RJ , Branch WJ , Warren RE , Neale G. Rectal organ culture as a model for the investigation of bacterial adhesion and invasion. J Clin Microh 1984; 37: 587–91.

Ohkusa T , Okayasu I , Tokoi S , Ozaki Y. Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hepatol 1993; 8: 116–18.

Burke DA , Clayden SA , Axon ATR . Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis. J Clin Pathol 1990; 43: 316–19.

Hunt CM , Harvey JA , Youngs ER , Irwin ST , Reid TM . Clinical and pathological variability of infection by enterohaemorrhagic (Vero-cytotoxin producing) Escherichia coli. J Clin Pathol 1989; 42: 847–52.

von Wulffen H , Russman H , Karch H. Verocytotoxin-producing Escherichia coli 02: H5 isolated from patients with ulcerative colitis. Lancet 1989; i: 1449–50.

Tabaqchali S , O'Donoghue DP , Bettleheim KA . Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978; 19: 108–13.

Perlmann P , Hammarstrom S , Lagercrantz R , Gustafson BE . Antigen from colon of germ-free rats and antibodies in human ulcerative colitis. Ann N Y Acad Sci 1965; 124: 377–94.

Koffler D , Minkowitz S , Rothman W , Garlock J. Immunocytochemical studies in ulcerative colitis and regional ileitis. Am J Pathol 1962; 41: 733–40.

Kemler BJ , Alpert E. Inflammatory bowel disease: study of cell-mediated cytotoxicity for isolated human colonic epithelial cells. Gut 1980; 21: 353–9.

Onderdonk AB , Bartlett JG . Bacteriological studies of experimental ulcerative coltis. Am J Clin Nutr 1979; 32: 258–65.

van der Waaij D , Cohen BJ , Anver MR . Mitigation of experimental inflammatory bowel disease in guinea pigs by selective elimination of aerobic gram negative intestinal flora. Gastroenterology 1974; 67: 460–72.

Watt J , Marcus SN , Marcus AJ . The comparative prophylactic effects of sulphasazine, predisolone and azathioprine in experimental colonic ulceration. J Pharm Pharmacol 1980; 32: 873–4.

Kraft SC , Fitch FW , Kirsner JB . Histological and immunohistochemical features of the Auer colitis in rabbits. Am J Pathol 1963; 43: 913–23.

Mee AS , McLaughlan JE , Hodgson HJF , Jewell DP . Chronic immune colitis in rabbits. Gut 1979; 20: 1–5.

Halpern B , Zweibaum A , Oriol Palou R , Morard JC . Experimental immune ulcerative colitis. In: Meischer PA , Graber P , eds. Immunopathology. Vth International Symposium 1967. Basel: Schwabe, 1971: 161–78.

Cooke EM , Filipe MI , Dawson IMP . The production of colonic autoantibodies in rabbits by immunisation with Escherichia coli. J Pathol Bacteriol 1968; 96: 125–30.

Onderdonk AB , Steeves RM , Cisneros RL , Bronson RT . Adoptive transfer of immune enhancement of experimental ulcerative colitis. Inf Immun 1984; 46: 64–7.

Connor EM , Aiko S , Grisham M. Genetically engineered models of inflammatory bowel disease. Curr Opin Gastroenterol 1994; 10: 358–64.

Cave DR , Mitchell DN , Brooke BN . Evidence of an agent transmissible from ulcerative colitis tissue. Lancet 1976; i: 1311–15.

Taub RN , Sachar D , Siltzbach LE , Janowitz H. Transmission of ileitis and sarcoidosis granulomas to mice. Transcr Assoc Am Physicians 1974; 87: 219–24.

Winkelstein A , Schwartzman G. The use of concentrated, and purified antitoxic B. coli serum in the treatment of indeterminate ulcerative colitis. Am J Dig Dis 1942; 9: 133–6.

Davies PS , Rhodes J , Heatley RV , Owen E. Metronidazole in the treatment of chronic proctitis: a controlled trial. Gut 1977; 18: 680–1.

Chapman RW , Selby WS , Jewell DP . Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986; 27: 1210–12.

Dickinson RJ , O'Connor HJ , Pinder I , Hamilton I , Johnston D , Axon ATR . Double blind trial of oral vancomycin as adjunctive treatment in acute ulcerative colitis. Gut 1985; 21: 787–92.

Collins EN , Hewlett JS . Succinyl sulfathiazole (sulfasuxidine) in the treatment of chronic ulcerative colitis. A report of 55 cases followed two years; its value by retention enema in early cases. Gastroenterology 1946; 7: 549–54.

Hartley MG , Hudson MJ , Swarbrick ET , Grace RH , Gent AE , Hellier MD . Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis. Aliment Pharmacol Ther 1996; 10: 157–63.

West B , Lendrum R , Hill MJ , Walker G. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut 1974; 15: 960–5.

Burke DA , Axon ATR , Clayden SA , Dixon MF , Johnston D , Lacey RW . The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990; 4: 123–9.

Lobo AJ , Burke DA , Sobala GM , Axon ATR . Oral tobramycin in ulcerative colitis: effect on maintenance of remission. Aliment Pharmacol Ther 1993; 7: 155–8.

McCann ML , Abrams RS , Nelson RPJ . Recolonization therapy with nonadhesive Escherichia coli for treatment of inflammatory bowel disease. Ann N Y Acad Sci 1994; 730: 243–5.

Bennet JD , Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; i: 164.